Immuno-oncology program (Spotlight Therapeutics)

N/A

Report date: 2025/08/28 17:42:40

Base Information

Drug NameImmuno-oncology program (Spotlight Therapeutics)
Drug Alias NameI-O program (Spotlight Therapeutics)
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpotlight Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpotlight Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A